The impact of the International Linked Clinical Trials programme (iLCT)
Since its inception in 2012 the Cure Parkinson’s research team has generated dossiers on 159 potential treatments to be evaluated by the iLCT committee – 32 of these have been tested in 41 different clinical trials, across 17 countries, with more than 4,700 people living with Parkinson’s participating in these trials. Cure Parkinson’s has directed £10.4 million of research funding towards iLCT related projects and the iLCT programme has attracted tenfold this amount in external investment into disease-modifying trials for Parkinson’s. Cure Parkinson’s is collaborating with organisations around the world to get as many clinical trials underway as possible with the ultimate aim of making disease-modifying treatments a reality for people living with Parkinson’s.
We are sorry that this content was not useful for you
Let us improve this content
Can you tell us how we can improve this content?